AltraVue Capital LLC Reduces Position in Siga Technologies Inc. $SIGA

AltraVue Capital LLC decreased its holdings in Siga Technologies Inc. (NASDAQ:SIGA) by 3.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,417,514 shares of the company’s stock after selling 83,630 shares during the period. Siga Technologies accounts for about 1.8% of AltraVue Capital LLC’s holdings, making the stock its 22nd biggest position. AltraVue Capital LLC owned 3.38% of Siga Technologies worth $22,120,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of SIGA. BNP Paribas Financial Markets boosted its holdings in Siga Technologies by 34.1% in the 2nd quarter. BNP Paribas Financial Markets now owns 4,661 shares of the company’s stock worth $30,000 after buying an additional 1,184 shares during the period. State of Alaska Department of Revenue bought a new position in shares of Siga Technologies in the third quarter worth $34,000. Tower Research Capital LLC TRC boosted its holdings in shares of Siga Technologies by 116.6% in the second quarter. Tower Research Capital LLC TRC now owns 6,817 shares of the company’s stock worth $44,000 after acquiring an additional 3,669 shares during the period. Bailard Inc. purchased a new position in shares of Siga Technologies in the second quarter valued at $78,000. Finally, Corient Private Wealth LLC raised its stake in shares of Siga Technologies by 16.4% during the 2nd quarter. Corient Private Wealth LLC now owns 14,097 shares of the company’s stock valued at $92,000 after purchasing an additional 1,985 shares during the period. 55.40% of the stock is currently owned by hedge funds and other institutional investors.

Siga Technologies Price Performance

Shares of Siga Technologies stock opened at $6.22 on Wednesday. Siga Technologies Inc. has a 1 year low of $4.95 and a 1 year high of $9.62. The firm has a market cap of $445.41 million, a PE ratio of 6.10 and a beta of 0.97. The company has a 50 day simple moving average of $6.60 and a two-hundred day simple moving average of $7.33.

Wall Street Analyst Weigh In

SIGA has been the subject of several analyst reports. Wall Street Zen downgraded Siga Technologies from a “strong-buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings downgraded shares of Siga Technologies from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, January 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Siga Technologies Profile

Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.

Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.